ES435500A1 - Un procedimiento para la obtencion de un preparado terapeu- tico solido. - Google Patents

Un procedimiento para la obtencion de un preparado terapeu- tico solido.

Info

Publication number
ES435500A1
ES435500A1 ES435500A ES435500A ES435500A1 ES 435500 A1 ES435500 A1 ES 435500A1 ES 435500 A ES435500 A ES 435500A ES 435500 A ES435500 A ES 435500A ES 435500 A1 ES435500 A1 ES 435500A1
Authority
ES
Spain
Prior art keywords
stomach
active ingredient
therapeutic preparation
remaining
solid therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES435500A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ES435500A1 publication Critical patent/ES435500A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES435500A 1974-03-12 1975-03-11 Un procedimiento para la obtencion de un preparado terapeu- tico solido. Expired ES435500A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (cg-RX-API-DMAC7.html) 1974-03-12 1974-03-12

Publications (1)

Publication Number Publication Date
ES435500A1 true ES435500A1 (es) 1977-02-01

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
ES435500A Expired ES435500A1 (es) 1974-03-12 1975-03-11 Un procedimiento para la obtencion de un preparado terapeu- tico solido.

Country Status (12)

Country Link
US (1) US3976764A (cg-RX-API-DMAC7.html)
JP (1) JPS5512411B2 (cg-RX-API-DMAC7.html)
BE (1) BE826498A (cg-RX-API-DMAC7.html)
CA (1) CA1054056A (cg-RX-API-DMAC7.html)
CH (1) CH604719A5 (cg-RX-API-DMAC7.html)
DE (1) DE2510620C2 (cg-RX-API-DMAC7.html)
DK (1) DK142802B (cg-RX-API-DMAC7.html)
ES (1) ES435500A1 (cg-RX-API-DMAC7.html)
FR (1) FR2263744B1 (cg-RX-API-DMAC7.html)
GB (1) GB1507521A (cg-RX-API-DMAC7.html)
NL (1) NL7502952A (cg-RX-API-DMAC7.html)
SE (1) SE409286B (cg-RX-API-DMAC7.html)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
EP0083372B1 (en) * 1981-07-15 1988-05-18 Key Pharmaceuticals, Inc. Sustained release theophyline
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS5953410A (ja) * 1982-09-20 1984-03-28 Fujisawa Pharmaceut Co Ltd 新型ソフトカプセル剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
JPS61107782U (cg-RX-API-DMAC7.html) * 1984-12-19 1986-07-08
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
AU654143B2 (en) * 1990-06-25 1994-10-27 Du Pont Merck Pharmaceutical Company, The Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (cg-RX-API-DMAC7.html) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
ID26082A (id) 1998-03-19 2000-11-23 Briston Myers Squib Company Sistem pengiriman lepas terkendali dwifasa untuk zat-zat farmasi kelarutan tinggi dan metodenya
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
MXPA05008843A (es) * 2003-02-21 2005-10-18 Lek Pharmaceuticals Sistema terapeutico que comprende amoxicilina y acido clavulanico.
AU2004289221B2 (en) * 2003-11-04 2009-12-17 Supernus Pharmaceuticals, Inc Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
EP2068844A4 (en) * 2006-09-04 2013-01-23 Panacea Biotec Ltd PROGRAMMABLE RELEASE TECHNIQUE BY FLOATING SYSTEM
WO2009087665A2 (en) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Novel gastroretentive drug delivery system
GB2460915B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
KR20110042366A (ko) * 2008-08-18 2011-04-26 팀 아카데미 오브 파마슈티컬 사이언스 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
JP5594484B2 (ja) * 2009-07-06 2014-09-24 杏林製薬株式会社 中空構造を有する錠剤
CN105726460A (zh) * 2010-07-05 2016-07-06 雅戈泰克股份公司 剂型
WO2014014348A1 (en) * 2012-07-16 2014-01-23 APET Holding B.V. Gastro-retentive drug delivery system
EP2731609A1 (en) * 2011-07-14 2014-05-21 APeT Holding B.V. Nicotinamide compositions and the therapeutic use thereof
WO2013054285A1 (en) 2011-10-11 2013-04-18 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
PT2719376E (pt) 2012-10-12 2015-07-06 Omya Int Ag Sistemas de formulação e ministração de medicamentos gastrorretentivos e o seu método de preparação usando carbonato de cálcio funcionalizado
CN106573015B (zh) 2014-06-11 2021-11-26 麻省理工学院 肠溶弹性体
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
CN107592803B (zh) 2015-05-01 2021-01-22 麻省理工学院 可触发形状记忆感应装置
JP7085473B2 (ja) 2015-10-23 2022-06-16 リンドラ セラピューティクス， インコーポレイティド 治療薬の持続放出用の胃内滞留システム及びその使用方法
ES2963058T3 (es) 2015-12-08 2024-03-25 Lyndra Therapeutics Inc Configuraciones geométricas para sistemas de residencia gástrica
CA3018011A1 (en) * 2016-03-18 2017-09-21 Grunenthal Gmbh Floating pharmaceutical dosage form
US12109305B2 (en) 2016-05-27 2024-10-08 Lyndra Therapeutics, Inc. Materials architecture for gastric residence systems
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
EP3518902A4 (en) 2016-09-30 2020-07-08 Lyndra, Inc. GASTRIC RESIDENCE SYSTEMS FOR LONG-TERM ADMINISTRATION OF ADAMANTANE CLASS MEDICINES
US12023406B2 (en) 2017-06-09 2024-07-02 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
WO2021176361A1 (en) * 2020-03-02 2021-09-10 Craft Health Pte Ltd Method of manufacturing oral dosage forms for extended drug release
ES2955784T3 (es) * 2020-10-14 2023-12-07 Hannes Bichsel Granos biogranulados espumados
WO2023166225A1 (en) * 2022-03-04 2023-09-07 APET Holding B.V. Digestive enzyme formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Also Published As

Publication number Publication date
US3976764A (en) 1976-08-24
SE409286B (sv) 1979-08-13
BE826498A (fr) 1975-06-30
FR2263744B1 (cg-RX-API-DMAC7.html) 1978-11-24
GB1507521A (en) 1978-04-19
JPS5512411B2 (cg-RX-API-DMAC7.html) 1980-04-02
DE2510620A1 (de) 1975-09-18
DK97875A (cg-RX-API-DMAC7.html) 1975-09-13
NL7502952A (nl) 1975-09-16
DK142802C (cg-RX-API-DMAC7.html) 1981-09-21
FR2263744A1 (cg-RX-API-DMAC7.html) 1975-10-10
DK142802B (da) 1981-02-02
CA1054056A (en) 1979-05-08
DE2510620C2 (de) 1984-01-05
CH604719A5 (cg-RX-API-DMAC7.html) 1978-09-15
SE7502725L (cg-RX-API-DMAC7.html) 1975-09-15
JPS50121418A (cg-RX-API-DMAC7.html) 1975-09-23

Similar Documents

Publication Publication Date Title
ES435500A1 (es) Un procedimiento para la obtencion de un preparado terapeu- tico solido.
ES423856A1 (es) Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino.
ZA837407B (en) Lyophilized compositions,preparation and use thereof
DE2964311D1 (en) An analgesic effervescent powder and process for its preparation
CA984709A (en) Apparatuses for disintegration of straw and similar material
CA963746A (en) Body implant material
IL52081A (en) Pharmaceutical compositions for barium opacification of the digestive tract and process for preparing them
JPS57109715A (en) Rapid decaying compression molded article containing pharmaceutically active substance
AU4230972A (en) Layered bolus for animal husbandry providing for immediate and sustained release of medicament
JPS5572117A (en) Analgesic tablet and its manufacture
AU457051B2 (en) Improvements relating to in vitro determination of active substance in a body
JPS5442380A (en) Regenerative capsule
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
CH611132A5 (en) Preparation for the controlled release of an effective amount of a biologically active material to the environment, and use of this preparation
GB862376A (en) Sustained release pharmaceutical tablet
SE7407561L (cg-RX-API-DMAC7.html)
JPS5513252A (en) Preventive and remedy for swine dysentry
JPS526660A (en) Production of lactulose-including powders for livestock feed
ES436179A1 (es) Procedimiento para intensificar la eficacia de medicamentos que in vivo o in vitro demuestren una afinidad de enlace a proteinas de la sangre.
CA964749A (en) Controlled feeding of powdered material
JPS5678071A (en) Positive plate for lead acid battery
CA1031260A (en) Pharmaceutical capsule shell compositions
JPS52130905A (en) Medicinal composition
JPS646084A (en) Latent heat-type heat storage material
JPS5350319A (en) Drug discharging means of medical capsule